BioLife Plasma Services
The Nonclinical Safety Lead owns the safety strategy for the AIRx portfolio, designing nonclinical safety packages and directing CRO execution to ensure data is interpretable and AI-ready. This role involves embedding within the DMTA cycle from early hit assessment through IND-enabling studies to flag liabilities early and build robust nonclinical dossiers. The position combines scientific strategy with hands-on project toxicology in a fast-paced, biotech-style environment.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
AIRx, Sr. Director, Nonclinical Safety Lead
Takeda Pharmaceutical Company Limited
Senior Director, Toxicology
Disc Medicine
Senior Director, Toxicology
Scripps Research
Director, Toxicology
Praxis Precision Medicines, Inc.
Director of Nonclinical Safety
Isomorphic Labs